Brainsway (BWAY) Long-Term Investments (2018 - 2025)

Brainsway (BWAY) posted quarterly Long-Term Investments of $14.7 million for Q4 2025, up 168.47% on a QoQ basis from $5.5 million in Q2 2025.

Brainsway (BWAY) Long-Term Investments (2018 - 2025) Analysis & Trends

Brainsway (BWAY) has reported Long-Term Investments for 3 consecutive years, with $14.7 million the latest figure, recorded in Q4 2025.

  • Quarterly Long-Term Investments changed N/A year-over-year to $14.7 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $14.7 million (changed N/A YoY) and the FY2025 annual result came in at $14.7 million, changed N/A from the prior year.
  • Long-Term Investments rose to $14.7 million in Q4 2025 per BWAY's latest filing, from $5.5 million in the prior quarter.
  • Over the last five years, Long-Term Investments for BWAY reached as high as $14.7 million in Q4 2025 and fell as low as $5.5 million in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Investments (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn 1.09 Bn
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn -
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn -
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn -
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn 285.60 Mn
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn -
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn 166.25 Mn
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn -
9 Smith & Nephew 25.80 Bn 25.22 Bn - 121.00 Mn
10 Brainsway 646.63 Mn 587.74 Mn 11.68 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 14.66 Mn
Jun 30, 2025 5.46 Mn
Mar 31, 2019 1.01 Mn
Dec 31, 2018 1.01 Mn
Sep 30, 2018 1.02 Mn
Jun 30, 2018 1.01 Mn